FDA Drug Application (021169) for RAZADYNE by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021169
Product Number001
FormTABLET;ORAL
DosageEQ 4MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRAZADYNE
Active IngredientGALANTAMINE HYDROBROMIDE

Active IngredientCount
List of drugs with Active Ingredient GALANTAMINE HYDROBROMIDE3


Back to FDA Applications sponsored by JANSSEN PHARMS